CompletedPHASE1, PHASE2NCT00415506
Rituximab in the Treatment of Scleritis and Non-Infectious Orbital Inflammation
Studying Infectious scleritis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Oregon Health and Science University
- Principal Investigator
- James T Rosenbaum, MDOregon Health and Science University
- Intervention
- Rituximab(drug)
- Enrollment
- 20 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2007 – 2011
Study locations (1)
- Oregon Health & Science University, Portland, Oregon, United States
Collaborators
Genentech, Inc.
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00415506 on ClinicalTrials.gov